Exploring the effects of calycosin on anthracycline-induced cardiotoxicity: a network pharmacology, molecular docking, and experimental study
BackgroundChemotherapy with anthracyclines can cause cardiotoxicity, possibly leading to stopping treatment in some cancer patients. In cardio-oncology research, preventing and minimizing anthracycline-induced cardiotoxicity (AIC) is a hot issue. For the treatment of AIC, calycosin (CA), an isoflavo...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2024-03-01
|
| Sarja: | Frontiers in Cardiovascular Medicine |
| Aiheet: | |
| Linkit: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1286620/full |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|